Financials MariMed Inc.

Equities

Market Closed - OTC Markets Other stock markets 03:56:10 2024-04-26 pm EDT			5-day change	1st Jan Change
0.2666 ^USD	-0.22%		-1.26%	-2.98%

Apr. 11	MariMed Inc. acquired Allgreens Dispensary, LLC.	CI
Apr. 09	MariMed Inc. completed the acquisition of Operating assets of Our Community Wellness & Compassionate Care Center, Inc for $5.3 million.	CI

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025
Capitalization ¹	139	143.3	288.6	120.9	103.4	101.1	-
Enterprise Value (EV) ¹	139	143.3	283.2	147	103.4	173.7	166.6
P/E ratio	-1.58 x	47 x	43.3 x	-	-	-	-
Yield	-	-	-	-	-	-	-
Capitalization / Revenue	3.05 x	2.81 x	2.38 x	0.9 x	0.7 x	0.64 x	0.58 x
EV / Revenue	3.05 x	2.81 x	2.33 x	1.1 x	0.7 x	1.1 x	0.96 x
EV / EBITDA	-	-	6.57 x	4.54 x	4.19 x	6.73 x	4.48 x
EV / FCF	-	-	15.8 x	-30.4 x	-	-24.5 x	23.5 x
FCF Yield	-	-	6.35%	-3.28%	-	-4.09%	4.26%
Price to Book	-	-	-	-	-	-	-
Nbr of stocks (in thousands)	225,065	304,817	333,653	339,462	376,126	379,394	-
Reference price ²	0.6178	0.4700	0.8650	0.3562	0.2748	0.2666	0.2666
Announcement Date	4/1/20	3/23/21	3/16/22	3/1/23	3/6/24	-	-

¹USD in Million²USD

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025
Net sales ¹	45.6	50.9	121.5	134	148.6	158	174.1
EBITDA ¹	-	-	43.13	32.38	24.67	25.8	37.2
EBIT	-	-	26.86	20.37	-	-	-
Operating Margin	-	-	22.12%	15.2%	-	-	-
Earnings before Tax (EBT)	-	-	23.82	-	-	-	-
Net income	-81.18	-	7.225	-	-	-	-
Net margin	-178.02%	-	5.95%	-	-	-	-
EPS	-0.3900	0.0100	0.0200	-	-	-	-
Free Cash Flow ¹	-	-	17.98	-4.829	-	-7.1	7.1
FCF margin	-	-	14.8%	-3.6%	-	-4.49%	4.08%
FCF Conversion (EBITDA)	-	-	41.69%	-	-	-	19.09%
FCF Conversion (Net income)	-	-	248.89%	-	-	-	-
Dividend per Share	-	-	-	-	-	-	-
Announcement Date	4/1/20	3/23/21	3/16/22	3/1/23	3/6/24	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4
Net sales ¹	33.21	31.04	31.28	32.99	33.91	35.83	34.38	36.52	38.8	38.9	36.9	38.7	40.2	42.1
EBITDA ¹	12.92	8.262	10.36	8.937	8.597	4.486	7.076	6.312	6.055	5.233	5.4	5.8	6.8	7.8
EBIT	6.619	1.204	-	-	5.736	3.089	-	-	-	-	-	-	-	-
Operating Margin	19.93%	3.88%	-	-	16.91%	8.62%	-	-	-	-	-	-	-	-
Earnings before Tax (EBT)	6.132	0.7681	-	-	-	-	-	-	-	-	-	-	-	-
Net income	2.02	-6.508	-	-	-	-	-	-	-	-	-	-	-	-
Net margin	6.08%	-20.96%	-	-	-	-	-	-	-	-	-	-	-	-
EPS	0.0100	-0.0200	-	-	-	-	-	-	-	-	-	-	-	-
Dividend per Share	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Announcement Date	11/15/21	3/16/22	5/10/22	8/8/22	11/7/22	3/1/23	5/8/23	8/2/23	11/8/23	3/6/24	-	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025
Net Debt ¹	-	-	-	26.1	-	72.6	65.5
Net Cash position ¹	-	-	5.37	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	0.8067 x	-	2.814 x	1.761 x
Free Cash Flow ¹	-	-	18	-4.83	-	-7.1	7.1
ROE (net income / shareholders' equity)	-	-	43.5%	45.9%	-	-	12.5%
ROA (Net income/ Total Assets)	-	-	21.5%	16.1%	-	4.1%	8.4%
Assets	-	-	33.53	-	-	-	-
Book Value Per Share	-	-	-	-	-	-	-
Cash Flow per Share ²	-	-	0.1000	0.0200	-	0.0200	0.0400
Capex ¹	-	-	17.9	12.1	-	12.2	5
Capex / Sales	-	-	14.72%	9.06%	-	7.72%	2.87%
Announcement Date	4/1/20	3/23/21	3/16/22	3/1/23	3/6/24	-	-

¹USD in Million²USD

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.2666 USD

Average target price

0.5 USD

Spread / Average Target

+87.55%